
Areas of Expertise
Conditions I Treat
- Blood disorders and hemoglobinopathies
- Anemia and cancer
- Blood clots and cancer
My Specialties
- Hematology
- Anticoagulation
Get to Know Me
A hematologist-oncologist is a doctor who treats cancers of the blood. This doctor is a hematologist (HEE-muh-TAH-loh-jist) who diagnoses and treats blood disorders. They also are an oncologist (cancer doctor).
- Assistant Attending Physician
Conditions I Treat
- Blood disorders and hemoglobinopathies
- Anemia and cancer
- Blood clots and cancer
- Thrombocytopenia and other bleeding disorders
- Rare blood cancers and conditions
- Complications of cancer
My Specialties
- Hematology
- Anticoagulation
Education
- MD, Jefferson Medical College
Residencies
- Internal Medicine - Los Angeles County+University of Southern California Medical Center
Fellowships
- Hematology and Medical Oncology - Boston University School of Medicine
- Hemostasis and Thrombosis - Memorial Sloan Kettering Cancer Center
Board Certifications
- Internal Medicine
- Medical Oncology
- Hematology
Insurance Information
Understanding your insurance options is an important part of managing your cancer care. We have relationships with many common healthcare providers and plans.
In Network Coverage Type
PPO
In Network Coverage Type
PPO, POS, EPO, HMO
In Network Coverage Type
HMO, PPO
In Network Coverage Type
HMO, EPO PPO, POS
In Network Coverage Type
PPO, POS, EPO, HMO
Offers a qualified health plan from the Health Insurance Marketplace. Call Emblem to learn more.
In Network Coverage Type
PPO, HMO
In Network Coverage Type
PPO
In Network Coverage Type
HMO, EPO
Offers a qualified health plan from the Health Insurance Marketplace. Call Fidelis to learn more.
In Network Coverage Type
EPO, HMO, PPO, POS
Offers a qualified health plan from the Health Insurance Marketplace. Call Healthfirst to learn more.
In Network Coverage Type
HMO
In Network Coverage Type
PPO
In Network Coverage Type
EPO
In Network Coverage Type
EPO
In Network Coverage Type
Federal Government
In Network Coverage Type
HMO
City Employee Health Plans (Gold and Gold Care)
In Network Coverage Type
PPO, POS, EPO, HMO
In Network Coverage Type
State Government
Don't see your carrier or plan? We can help you understand your coverage.
If you don't have health insurance or are worried that your care may not be fully covered, our financial assistance programs may be able to help.
If you have questions about insurance, call us at 646-497-9176.
Make an Appointment

Contact and Location
Dr. Wilkins sees patients at one location.






Looking to see a doctor at a different location? See all MSK locations.
Colleagues
Doctors at Memorial Sloan Kettering work as teams, with specialists from all different areas. This allows us to consider all your needs together, and to give you the best possible care.
Clinical Trials

Memorial Sloan Kettering's doctors and scientists are constantly developing new treatments for cancer. MSK is typically running hundreds of clinical trials at a given time.
You may be able to participate in a clinical trial even if you are new to MSK. Search our online directory to find trial information and see more about who can participate.
Search clinical trialsResearch and Publications
Piedra K, Peterson T, Tan C, Orozco J, Hultcrantz M, Hassoun H, Mailankody S, Lesokhin A, Shah U, Lu S, Patel D, Derkach A, Wilkins CR, Korde N. Comparison of venous thromboembolism incidence in newly diagnosed multiple myeloma patients receiving bortezomib, lenalidomide, dexamethasone (RVD) or carfilzomib, lenalidomide, dexamethasone (KRD) with aspirin or rivaroxaban thromboprophylaxis. Br J Haematol. 2022 Jan;196(1):105-109. doi: 10.1111/bjh.17772. Epub 2021 Aug 15. PubMed PMID: 34396516.
Soff GA, Miao Y, Bendheim G, Batista J, Mones JV, Parameswaran R, Wilkins CR, Devlin SM, Abou-Alfa GK, Cercek A, Kemeny NE, Sarasohn DM, Mantha S. Romiplostim Treatment of Chemotherapy-Induced Thrombocytopenia. J Clin Oncol. 2019 Nov 1;37(31):2892-2898. doi: 10.1200/JCO.18.01931. Epub 2019 Sep 23. PubMed PMID: 31545663; PubMed Central PMCID: PMC6823892.
Soff GA, Mones J, Wilkins C, Devlin S, Haegler-Laube E, Wills J, Sarasohn DM, Juluru K, Singer M, Miao Y, Batista J, Mantha S. Rivaroxaban treatment of cancer-associated venous thromboembolism: Memorial Sloan Kettering Cancer Center institutional experience. Res Pract Thromb Haemost. 2019 Jul;3(3):349-356. doi: 10.1002/rth2.12215. eCollection 2019 Jul. PubMed PMID: 31294321; PubMed Central PMCID: PMC6611365.
Tavakkoli M, Wilkins CR, Mones JV, Mauro MJ. A Novel Paradigm Between Leukocytosis, G-CSF Secretion, Neutrophil-to-Lymphocyte Ratio, Myeloid-Derived Suppressor Cells, and Prognosis in Non-small Cell Lung Cancer. Front Oncol. 2019;9:295. doi: 10.3389/fonc.2019.00295. eCollection 2019. PubMed PMID: 31080780; PubMed Central PMCID: PMC6497733.
Li V, Miao Y, Wilkins C, Soff G. Efficacy and Thrombotic Adverse Events of Romiplostim Use in Patients with Thrombocytopenia Related to Underlying Malignancies. Blood. 2017; 130(Suppl 1):2324—2324.
Dorff TB, Wilkins C, Hepgur M, Quinn DI. Durable complete remission from castration-resistant prostate cancer with sipuleucel-T after estrogen withdrawal. Clin Genitourin Cancer. 2014 Apr;12(2):e55-8. doi: 10.1016/j.clgc.2013.11.006. Epub 2013 Nov 14. PubMed PMID: 24331572.
Visit PubMed for a full listing of Dr. Wilkins’s journal articles. Pubmed is an online index of research papers and other articles from the US National Library of Medicine and the National Institutes of Health.
See all on PubMedPatient Reviews
Your trust is our main concern
We strive to keep reviews trustworthy, honest and fair. Learn more about our patient experience reviews.
4.8 197 reviews
- 4.8 Provider's Explanations Easy to Understand
- 4.8 Trusts Provider with Care
- 4.9 Provider Listened Carefully
- 4.8 Likelihood of Recommending Provider
excellent
He was very very professional, informative and genuine nice doctor.
Thank you
I checked into the video call but was never able to speak with this doctor. I was told he was running about 20 min behind which I was ok with, so I waited. But after waiting on the call for more than an hour and 45 min, I had to go as my phone was dying. I think they forgot me.
I never spoke with Dr Wilkins. We have a tele health visit for 3pm. I waited 20 mins before the nurse came on. Answered a few questions & was told the doctor would be on soon. At 3:30 someone called and said he was running late. I asked how late & was told she would call back in 3 mins. I never heard back. I tried connecting via the chat messaging on the video call. No response. I finally sent an email thru the portal after 4pm and asked to reschedule or have Dr Wilkins call me. I have yet to hear back from anyone
Disclosures
Doctors and faculty members often work with pharmaceutical, device, biotechnology, and life sciences companies, and other organizations outside of MSK, to find safe and effective cancer treatments, to improve patient care, and to educate the health care community.
MSK requires doctors and faculty members to report (“disclose”) the relationships and financial interests they have with external entities. As a commitment to transparency with our community, we make that information available to the public.
Cy R. Wilkins discloses the following relationships and financial interests:
-
AllMed Healthcare Management, LLC
Professional Services and Activities
If you’re a patient at MSK and would like more information about your doctor’s external relationships, please talk with your doctor.
The information published here is a complement to other publicly reported data and is for a specific annual disclosure period. There may be differences between information on this and other public sites as a result of different reporting periods and/or the various ways relationships and financial interests are categorized by organizations that publish such data.
This page and data include information for a specific MSK annual disclosure period (January 1, 2023 through disclosure submission in spring 2024). This data reflects interests that may or may not still exist. This data is updated annually.
Learn more about MSK’s COI policies here. For questions regarding MSK’s COI-related policies and procedures, email MSK’s Compliance Office at ecoi@mskcc.org.